Envoy Medical (COCH) Equity Average (2022 - 2026)
Envoy Medical's Equity Average history spans 5 years, with the latest figure at -$998500.0 for Q1 2026.
- On a quarterly basis, Equity Average rose 95.36% to -$998500.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$998500.0, a 95.36% increase, with the full-year FY2025 number at -$15.5 million, down 50.35% from a year prior.
- Equity Average hit -$998500.0 in Q1 2026 for Envoy Medical, up from -$9.9 million in the prior quarter.
- Over the last five years, Equity Average for COCH hit a ceiling of $1.5 million in Q4 2023 and a floor of -$46.3 million in Q2 2023.
- Historically, Equity Average has averaged -$20.7 million across 5 years, with a median of -$20.2 million in 2023.
- Biggest five-year swings in Equity Average: skyrocketed 104.88% in 2023 and later plummeted 1342.03% in 2024.
- Tracing COCH's Equity Average over 5 years: stood at -$30.9 million in 2022, then skyrocketed by 104.88% to $1.5 million in 2023, then plummeted by 1342.03% to -$18.7 million in 2024, then soared by 46.99% to -$9.9 million in 2025, then skyrocketed by 89.92% to -$998500.0 in 2026.
- Business Quant data shows Equity Average for COCH at -$998500.0 in Q1 2026, -$9.9 million in Q4 2025, and -$18.8 million in Q3 2025.